A handy pocket-sized leaflet for men who want to find out about the PSA test. It describes the test and explains how it can be used to diagnose prostate cancer and other prostate problems. These leaflets are ideal for displays and events. Suitable for health professionals and organisations to help promote prostate cancer awareness.

References  

  • Cancer Research UK. Prostate cancer incidence statistics [Internet]. 2014 [cited 2014 Sep 16]. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/incidence/#age
  • Cancer Research UK. Prostate cancer incidence statistics: Prostate cancer incidence by age (2011-2013) [Internet]. Cancer Research UK. 2016 [cited 2016 Jun 9]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence
  • Crawford ED. Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer. Urology. 2009 May;73(5):S4–10.
  • Kiciński M, Vangronsveld J, Nawrot TS. An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis. Little J, editor. PLoS ONE. 2011 Oct 31;6(10):e27130.
  • Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010. BMC Med. 2015 Dec;13(1).
  • Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013 Dec;64(6):876–92.
  • Mottet N, Bellmunt J, Briers E, Bolla M, Cornford P, De Santis M, et al. Guidelines on prostate cancer. European Association of Urology; 2016.
  • National Institute for Health and Care Excellence. Lower urinary tract symptoms: The management of lower urinary tract symptoms in men. NICE clinical guideline 97. 2010.
  • National Institute for Health and Care Excellence. Prostate Cancer: diagnosis and treatment. Full guideline 175. 2014.
  • National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NICE Guideline 12. June 2015 [Internet]. 2015. Available from: http://www.nice.org.uk/guidance/ng12/evidence/full-guidance-65700685
  • Popiolek M, Rider JR, Andrén O, Andersson S-O, Holmberg L, Adami H-O, et al. Natural History of Early, Localized Prostate Cancer: A Final Report from Three Decades of Follow-up. Eur Urol. 2013;63(3):428–35.
  • Prostate Cancer UK. Consensus statements on PSA testing in asymptomatic men in the UK [Internet]. 2016. Available from: www.prostatecanceruk.org/PSAconsensusHP
  • Public Health England. Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing [Internet]. GOV.UK; 2016. Available from: https://www.gov.uk/government/publications/prostate-cancer-risk-management-programme-psa-test-benefits-and-risks/prostate-cancer-risk-management-programme-pcrmp-benefits-and-risks-of-psa-testing
  • Rosario DJ, Lane JA, Metcalfe C, Donovan JL, Doble A, Goodwin L, et al. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ. 2012;344:d7894.

About this publication  

Updated: January 2017

To be reviewed: January 2019

Topic

Order printed copies of this publication

Before you order we would like to know who you are, and why you are ordering printed copies.